Previously, we have reported that pre-conditioning of primary rat cortical neurons with brain-derived neurotrophic factor (BDNF) may exert neuroprotective effects against 3-nitropropionic acid (3-NP), a mitochondrial complex II inhibitor. However, the underlying mechanisms, especially potential involvements of autophagy, remain elusive. In this work, we tested the hypothesis that BDNF may suppress 3-NP-induced autophagy to exert its neuroprotective effects by inducing the expression of p62/sequestosome-1 in primary cortical neurons. We found that 3-NP increased total level of microtubuleassociated protein 1A/1B-light chain (LC)-3 as well as the LC3-II/LC3-I ratio, an index of autophagy, in primary cortical neurons. BDNF decreased LC3-II/LC3-I ratio and timedependently induced expression of p62. Knockdown of p62 by siRNA restored LC3-II/LC3-I ratio and increased total LC3 levels associated with BDNF exposure; p62 knockdown also abolished BDNF-dependent neuroprotection against 3-NP.
Autophagy is a well-conserved and highly regulated mechanism that may be induced in response to nutrient deprivation for the degradation of macromolecules via the lysosomal system (Delgado et al. 2009 ). Under proper regulation, autophagy may help to promote cell survival, either by purging the cell of damaged organelles and toxic pathogens, or by regenerating metabolites for energy supply and support of growth under nutrient-limited conditions. In contrast, excessive or prolonged autophagy may contribute to cell death through self-digestion and degradation of essential cellular constituents (Reggiori and Klionsky 2002; Shintani and Klionsky 2004) . The autophagosomal marker proteins include Atg8 in yeast and microtubule-associated protein 1A/ 1B-light chain 3 (LC3) in mammals (Kabeya et al. 2000) . After its synthesis, LC3 is cleaved at its C-terminus to produce the cytosolic LC3-I, which is converted to LC3-II that is tightly associated with the autophagosomal membrane probably via conjugation to phosphatidylethanolamine (Kabeya et al. 2000 (Kabeya et al. , 2004 . Mammalian target of rapamycin (mTOR) can prevent the progression of autophagy through the regulation of autophagic genes (Jung et al. 2009; Yang and Klionsky 2010; Nazio and Cecconi 2013) . During acute injury, mTOR activation can prevent cell injury in the nervous system, as has been observed in dopaminergic neurons under oxidative stress; furthermore, degeneration can be prevented by activating mTOR and inhibiting autophagy (Choi et al. 2010) . In contrast, loss of mTOR activity can lead to autophagic cell death (Le et al. 2010) .
Another type of autophagic degradation, namely the selective autophagy, involves ubiquitin-binding proteins such as p62/sequestosome-1 (p62/sequestosome-1; hereby referred to as p62) (Kraft et al. 2010) . The p62 protein with 440 amino acids has an N-terminal Phox and Bem1p (PB1) domain followed by a ZZ type zinc finger domain, a PEST region containing putative phosphorylation sites, and a Cterminal ubiquitin-associated domain (Geetha and Wooten 2002) . The last domain binds ubiquitin non-covalently (Vadlamudi et al. 1996) , raising the possibility that p62 may be recruited to ubiquitinated protein aggregates as a result of its ability to bind polyubiquitin via the ubiquitinassociated domain (Donaldson et al. 2003) . The N-terminal PB1 domain serves the dual functions of p62 polymerization and binding to other PB1-containing proteins (Sanz et al. 1999; Lamark et al. 2003) . Several lines of evidence have shown that, in selective autophagy, p62 acts as a mediator in the formation of large aggregates/inclusions known as p62 bodies or sequestosomes , which recruit and transport ubiquitinated cargo to the autophagosome for degradation via association of p62 with the autophagosomal membrane constituent LC3-II (Pankiv et al. 2007; Komatsu and Ichimura 2010) . Notably, a recent study indicated that the siRNA targeting p62 induced the switch of LC3B-I to LC3B-II, an indicator of autophagic activity, in carcinoma cell lines (Nihira et al. 2014) , suggesting a pivotal role of p62 serving as an autophagy mediator.
In addition to its involvements in autophagy regulation, p62 has been shown to carry antioxidative effects. For example, a previous study revealed that p62 protected cells from oxidative damage induced by hydrogen peroxide (Du et al. 2009 ). Moreover, p62 that is localized to the mitochondria under physiological conditions is integral to normal mitochondrial dynamics and maintains mitochondrial genome stability (Seibenhener et al. 2013) . These results suggest that a heightened p62 level may carry a protective effect against mitochondrial dysfunction often resulting in oxidative stress.
We have demonstrated that pre-conditioning of primary cortical neurons with brain-derived neurotrophic factor (BDNF) exerts protective effects against neuronal death induced by mitochondrial complex II inhibitor 3-nitropropionic acid (3-NP) (Wu et al. , 2010 (Wu et al. , 2012 . Despite previous reports showing activation (Smith et al. 2014) or inhibition (Chen et al. 2013 ) of mTOR by BDNF, potential BDNF effects in autophagy regulation still remains to be fully investigated. Furthermore, whether BDNF-dependent neuroprotective effects involve p62 induction, mTOR activation, and autophagy regulation are also unknown. The present study was therefore conducted to address these issues.
Materials and methods
Chemicals and reagents BDNF and 3-NP were prepared as described in our previous reports (Wu et al. , 2010 . The stock solutions of rapamycin (2 mM; Cat. No. R0395; Sigma, St. Louis, MO, USA) and bafilomycin A1 (Baf-A1; 10 lM; Cat. No. B1793; Sigma) were dissolved in dimethyl sulfoxide (Sigma).
Primary fetal rat cortical culture All the procedures for animal care and preparation of fetal rat cortical cultures were performed humanely in accordance with the guidelines described in the 'User Manual of Laboratory Animal Center at National Yang-Ming University'. Primary neuronal cultures were prepared from cortices of Sprague-Dawley (SD) fetal rat brains at embryonic day 18 (E18) as previously described (Ju et al. 2004) . The pregnant SD rats were purchased from BioLASCO Taiwan Co. Ltd. (Taipei, Taiwan) . The rat cortical cultures were a neuron-enriched co-culture system as evidenced by more cells immunostained with antibodies recognizing microtubule-associated protein-2 (MAP-2) (approximately 85%) than with glial fibrillary acidic protein (GFAP) (approximately 15%), the respective cellular marker for neurons and astrocytes (Ju et al. 2004 ).
Transfection of siRNA
The detailed protocols for transfection of siRNAs into primary cortical cultures have been described in our earlier publication (Wu et al. 2012) . All the siRNAs, including the negative control siRNA with scrambled sequences, were purchased from GE Dharmacon Inc. (Lafayette, CO, USA). The target sequences for knocking down p62 in the Accell SMARTpool siRNA mixture are as follows: GCAUCUACAUUAAAGAGAA (A-089365-13), GUGGGAACU CGCUAUAAGU (A-089365-14), CCAACGUGAUUUGUGAUG G (A-089365-15), GUCCUAUGUGAAAGAUGAC (A-089365-16). The target sequences for the c-jun Accell SMARTpool siRNA mixture were as follows: CCGUCUGGUUGUAGGAAUA (A-089158-13), CUCUCAACUAUGUAUGUAC (A-089158-14), CC AUUUGUAAUAAAGUAUA (A-089158-15), GCGCUGUGAU CGUUUAUAA (A-089158-16). A non-targeting Accell siRNA (D-001910-01) was used as a negative control in all siRNA transfection experiments. Cortical cultures grown on 6-well or 24-well plates were transfected with the target siRNA or the negative control siRNA, 1 lM each, for 3 days (days in vitro 4-7; DIV4-7) in neurobasal medium supplemented with B27 (NB/B27). At the end of transfection, cells were washed once in fresh NB/B27 medium before further experimentation.
Hoechst staining and PI/Hoechst double staining Hoechst staining and propidium iodide (PI)/Hoechst double staining to, respectively, determine the extents of cell survival and death were performed as described in our previous publication; the definitions of 'Cell Survival (%)' in Hoechst staining and 'Death Index' in PI/Hoechst double staining were also described in details therein . caspase-3 (1 : 1000; Cat. No. 9664; Cell Signaling Technology), and c-Jun (1 : 1000; Cat. No. 9165; Cell Signaling Technology) were all diluted in 5% non-fat milk in Tween-20 in Tris-buffered saline (TTBS) buffer (0.05% Tween-20, 0.2 M NaCl in 20 mM Tris-HCl, pH 7.5). The mouse antibody against b-actin (1 : 7000; Cat. No. MAB1501; Millipore) was diluted in 5% non-fat milk in TTBS. The conditions for membrane wash, detection of immunoreactive signals, and quantification of signal intensities on the blots were performed as previously described (Wu et al. 2010) . The b-actin was included to serve as an internal control for equal loading of total cellular proteins in each lane.
Western blotting

Immunocytochemistry by confocal microscopy
The following primary antibodies were diluted in blocking buffer (2% normal goat serum, 0.3% Triton X-100 in 19 phosphate-buffered saline) at 1 : 100 for immunocytochemistry: the same rabbit antibody used to detect p62 and LC3 for western blotting, the mouse microtubule-associated protein ( Reverse transcription-coupled polymerase chain reaction (RT-PCR) and real-time quantitative PCR Extraction of total RNA from cortical cultures, reverse transcription for cDNA construction, and real-time quantitative PCR, as shown in Fig. 7 (c) and (d), were performed as previously described (Wu et al. 2010) . The glyceraldehyde 3-phosphate dehydrogenase was also included as an internal control for PCR reaction. The primers used in current study were: 5 0 -GGATGACGACTGGACGCATT-3 0 (forward) and 5 0 -TCTGGTGGGAGATGTGGGTA-3 0 (reverse) for p62-1; 5 0 -G GAAGCTGAAACATGGGCAC-3 0 (forward) and 5 0 -CAAACACC AGCCTTACCCGA-3 0 (reverse) for p62-2; 5 0 -AGAGACAGCCGC ATCTTCTTG-3 0 (forward) and 5 0 -CGACCTTCACCATCTTGTCT ATGA-3 0 (reverse) for glyceraldehyde 3-phosphate dehydrogenase.
The RT-PCR shown in Fig. 7 (a) and (b) was performed with the same pairs of primers for each target sequence in the Mastercycler from Eppendorf (Hamburg, Germany) according to the following program: denaturation at 95°C for 3 min followed by 35 cycles of denaturation at 95°C for 30 s, primer annealing at 59°C for 30 s, and extension at 72°C for 60 s; this was followed by a final extension at 72°C for 5 min.
Statistical analysis
Results are expressed as mean AE SEM from the sample numbers (N). For Hoechst staining and PI/Hoechst double staining, the N represents data collected from one independent experiment using one cortical culture. Each independent experiment contained 2-3 coverslips for every condition. On each coverslip, three vision fields were randomly selected for counting to obtain the average numbers of surviving cells in each vision field. The mean numbers of surviving cells for each independent experiment were therefore derived from a total of 6-9 vision fields out of 2-3 coverslips for the same condition. For western blotting showing quantitative results, each N represents data collected from one experiment using one culture; combined data from at least three independent using three different cultures are shown. For all the double immunofluorescence staining, representative images from three independent experiments using three different cultures are shown. Multiple groups were analyzed by a one-way analysis of variance (ANOVA) followed by a post-hoc Student-Newman-Keuls test. p-Values of less than 0.05 were considered significant.
Results
3-NP toxicity to cortical neurons involves autophagy
We have previously demonstrated that 3-NP exposure (2.5 mM for 24 h) causes significant cell death in rat cortical neurons . Because several lines of evidence suggested that 3-NP-induced cell death may involve autophagy activation (Zhang et al. 2009a,b; Solesio et al. 2013 ), we therefore first tested whether autophagy may also be induced in rat cortical neurons. Based on the immunoblots as shown in Fig. 1(a) and quantitative analyses of the relative band intensities, our results indicated an increased ratio of LC3-II/LC3-I at 4 h following 3-NP treatment; similar increases of LC3-II/LC3-I ratio were also observed after exposure to 3-NP for 2 h and 6 h, but statistical significance was not achieved (Fig. 1b) . Interestingly, further analysis revealed that 3-NP also enhanced total LC3 levels (LC3-I+LC3-II) at 4-6 h (Fig. 1c) . When individually examined, we found that 3-NP significantly increased LC3-II at 2-6 h ( Fig. 1d ). 3-NP also increased LC3-I at 6 h; however, statistical significance was not achieved (p = 0.091; Fig. 1d ).
Possibly as a result of this more prominent increase in LC3-I expression at 6 h, the increased LC3-II/LC3-I ratio by 3-NP was not significantly different from the control cultures ( Fig. 1b ) despite significant increases in LC3-II/b-actin at the same time point (Fig. 1d) . Thus, at selective time points, 3-NP exposure enhanced expression of total LC3, mainly LC3-II, and increased the extents of conversion from LC3-I to LC3-II, implying possible autophagy activation. We then sought to examine whether 3-NP-induced LC3 may colocalize to mitochondria and lysosomes by double immunofluorescence microscopy. The LC3, COX-IV, and LAMP-1 were used as the respective marker for autophagosomes, mitochondria, and lysosomes. Previously, it has been reported that 3-NP-induced striatal cell death is robustly attenuated by Baf-A1 (Zhang et al. 2009a) , an inhibitor for vacuolar type H + -ATPase (VATPase) capable of blocking the fusion of autophagosomes with lysosomes (Yoshimori et al. 1991) . Literature search revealed that Baf-A1 at 100 nM completely reversed the neuroprotective effects of insulin-like growth factor-I on primary rat Purkinje neurons (Bains et al. 2009 ); further, secretion of a-synuclein oligomers was increased when lysosomal activity is blocked by Baf-A1 at this same dosage in primary cortical neurons (Danzer et al. 2012) . Therefore, Baf-A1 at 100 nM was applied to cortical cultures to block autophagic flux. We found that 3-NP-induced cell death in cortical cultures was partially, but significantly, reversed by Baf-A1 based on Hoechst staining; however, Baf-A1 alone also resulted in approximately 20% cell death as compared to the solvent controls (Fig. 2a) . PI/Hoechst double staining revealed similar findings (Fig. 2b) . In addition to quantitative determination of cell survival, immunocytochemical studies with antibodies against MAP-2 and GFAP, the respective cellular marker for neurons and astrocytes, were conducted to observe the neuroprotective action of Baf-A1 against 3-NP. Figure 2 (c) demonstrated that Baf-A1 restored neuronal morphology with partial recovery of dendritic structures that were damaged by 3-NP. To further confirm this observation, western blotting was conducted. Immunoblots shown in Fig. 2 (d) clearly indicated that 3-NP decreased the expression of MAP-2, which was reversed by Baf-A1; quantitative analysis confirmed this finding (Fig. 2e) . In addition to MAP-2, we also examined the effects of Baf-A1 on LC3-II/ LC3-I ratio in the 3-NP-treated cortical cultures.
Immunoblotting and quantitative analysis shown, respectively, in Fig. 2 (f) and (g) indicated that Baf-A1 partially, but significantly, attenuated the 3-NP-induced increases in LC3-II/LC3-I ratio. These results, as shown in Fig. 2 , thus provide correlative evidence supporting the notion that 3-NP-induced increases in LC3-II/LC3-I ratio and cell death can both be attenuated, albeit in part, by Baf-A1, despite its modest cytotoxicity.
Induction of p62 contributes to BDNF-dependent autophagy inhibition and neuroprotection against 3-NP toxicity In our previous reports, we have already demonstrated that BDNF pre-conditioning exerts neuroprotection against 3-NPinduced cell death (Wu et al. 2009a (Wu et al. ,b, 2010 . Given above findings linking 3-NP toxicity to autophagy, we speculated that BDNF-dependent neuroprotection may involve autophagy regulation. Results indicated that BDNF (100 ng/mL) decreased the ratio of LC3-II/LC3-I, indicative of autophagy inhibition, at 4-8 h (Fig. 3a) . Unlike 3-NP that increased total LC3 expression during the 4-6 h of exposure time, BDNF did not significantly alter the expression of total LC3 during the 8-h treatment (data not shown). However, we found that BDNF time-dependently enhanced expression of p62, beginning at 4 h and lasting until 8 h in our neuronenriched cortical cultures (Fig. 3b) . Confocal microscopy revealed that the BDNF-induced p62 expression was localized in the MAP-2-positive cells (upper panels; Fig. 3c ), indicating neuronal expression of this protein; closer examination at the higher magnification demonstrated that the BDNF-induced p62 was mainly detected in the MAP-2-positive somata (arrows in the lower panels; Fig. 3c ). These results together indicated autophagy suppression and p62 induction upon exposure of cortical neurons to BDNF.
Because BDNF inhibited autophagy (Fig. 3a) while inducing p62 expression during 4-8 h (Fig. 3b) , we thus examined whether these two events were causally linked. The siRNAs targeting at p62 were applied to cortical cultures. Our results demonstrated that the BDNF-induced p62 was effectively suppressed by this siRNA mixture down to approximately 30% of the basal levels (Fig. 4a) . Consistent with its inhibitory effect on autophagy, p62 knockdown also partially, but significantly, recovered the LC3-II/LC3-I ratio decreased by BDNF (Fig. 4b) . BDNF pre-conditioning for 8 h followed by 3-NP exposure for additional 4 h increased p62 expression that was effectively suppressed by its siRNA (Fig. 4c) . Notably, BDNF attenuated 3-NPmediated increases in LC3-II/LC3-I ratio and this BDNF effect was also abrogated by p62 knockdown (Fig. 4d) , indicating that BDNF inhibits autophagy activation associated with mitochondrial inhibition via induction of p62. Further analysis of the immunoblots revealed that BDNF also down-regulated the 3-NP-induced increase in total LC3 levels, which was restored by the p62 siRNA (Fig. 4e) . When individually examined, similar results were observed for LC3-II (Fig. 4f ) and LC3-I (Fig. 4g) ; however, statistical significance was not achieved for LC3-I expression (Fig. 4g) . After confirming the effects of BDNF-dependent p62 induction on 3-NP-mediated autophagy activation, we analyzed its effects on 3-NP-induced neuronal death. We first examined the effects of p62 knockdown on the extents of The experimental conditions were the same as described in (a) except that immunostaining with the antibodies against MAP-2 (red) and glial fibrillary acidic protein (green), the respective cellular marker for neurons and astrocyte, was conducted before confocal microscopy. Scale bar: 20 lm. Note that Baf-A1 restored the dendritic morphology that was damaged by 3-NP. (d and e) The experimental conditions were the same as in (c) except that MAP-2 was detected by western blotting; b-actin was also included as an internal control for equal loading of proteins in each lane (d). Quantitative results of MAP-2/b-actin are shown in (e). N = 5. Mean AE SEM. * and # denote p < 0.05. (f and g) Cortical cultures were exposed to 3-NP (2.5 mM) with Baf-A1 (100 nM) or its solvent 1% DMSO for 24 h before detection of LC3 by western blotting. Quantitative results of LC3-II/LC3-I ratio are shown in (g). N = 5. Mean AE SEM. *, #, and § all denote p < 0.05. apoptosis-like activity by western blotting. Results shown in Fig. 4 (h) revealed that 3-NP enhanced caspase-3 cleavage, which was in part suppressed by BDNF; however, downregulation of p62 by siRNA partly reversed this antiapoptotic effect of BDNF with a heightened extent of caspase-3 cleavage. Hoechst staining revealed that the p62 siRNA also abolished 3-NP resistance as a result of BDNF pre-conditioning; indeed, suppression of p62 alone appeared to show modest cytotoxicity, either with or without 3-NP challenge (Fig. 4i) . Similar results were observed when PI/ Hoechst double staining was conducted (Fig. 4j) . Taken together, our results suggest that BDNF induces expression of p62, thereby counteracting 3-NP-mediated autophagy activation and neurotoxicity in primary cortical cultures. In addition to modulating the ratio of LC3-II/LC3-1, both p62 and 3-NP also affect the total cellular levels of LC3, particularly LC3-II.
The mTOR pathway mediates BDNF-dependent p62 induction and its neuroprotection mTOR activation is known to suppress autophagy, which can be reversed by its inhibitor rapamycin (Meijer and Codogno Cortical cultures were transfected with p62 siRNA (1 lM) or negative control (NC) siRNA (1 lM) for 72 h; at the end of transfection, cortical cultures were exposed to brain-derived neurotrophic factor (BDNF) (100 ng/mL) for 4 h before detection of p62 (a) and LC3 (b) . N = 3 in both (a) and (b). Mean AE SEM. * and # denote p < 0.05. (c) Cortical cultures were transfected with p62 siRNA (1 lM) or NC siRNA (1 lM) for 72 h; at the end of transfection, the cultures were exposed to BDNF (100 ng/mL) for 8 h followed by incubation with 3-NP (2.5 mM) or empty medium for additional 6 h before detection of p62. N = 5. Mean AE SEM. *, #, and § all denote p < 0.05. (d) The experimental conditions were the same as described in (c) except LC3 was detected by western blotting. Quantitative results of LC3-II/LC3-I ratio (d), total LC3/b-actin ratio (e), LC3-II/b-actin ratio (f), and LC3-I/ b-actin ratio (g) are shown. N = 3. Mean AE SEM. *, #, and § all denote p < 0.05. (h) The experimental conditions were the same as described in (c) except that 3-NP incubation was extended to 24 h and that caspase-3 was detected by western blotting. N = 7. Mean AE SEM. *, #, and § all denote p < 0.05. (i and j) Cortical cultures were transfected with p62 siRNA (1 lM) or NC siRNA (1 lM) for 72 h. Afterwards, the cultures were exposed to BDNF (100 ng/mL) for 8 h followed by incubation with 3-NP (2.5 mM) or empty medium for additional 24 h (i) or 16 h (j). Cells were then subjected to Hoechst staining (i) or propidium iodide/Hoechst double staining (j) to determine the extents of cell survival and death, respectively. N = 6 in both (i) and (j). Mean AE SEM. *, #, and § all denote p < 0.05.
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; Jung et al. 2010) . Given that BDNF can inhibit autophagy, we tested whether mTOR activation was involved in BDNF-dependent autophagy inhibition. Results indicated that exposure to BDNF for 2 h induced mTOR phosphorylation at Ser2448, which sustained until at least 6 h (Fig. 5a) . Phosphorylation of p70S6K at Thr389 has been used as a hallmark of mTOR activation and correlated with autophagy inhibition in various experimental model systems (Scott et al. 2004; Boland et al. 2008) . We observed that BDNF also increased phosphorylation of p70S6K at Thr389 (Fig. 5b) , which was fully suppressed by the mTOR inhibitor rapamycin (Fig. 5c) ; rapamycin indeed completely inhibited the basal level of p70S6K phosphorylation (Fig. 5c) . These results thus indicated that BDNF is capable of activating mTOR pathways in primary rat cortical cultures.
To examine the roles of mTOR in BDNF-mediated p62 induction and neuroprotection, rapamycin was used to suppress mTOR activity. We found that rapamycin completely abolished BDNF-induced p62 expression in the cortical cultures (Fig. 6a) . In the cortical cultures preconditioned with BDNF followed by 3-NP exposure, rapamycin also effectively attenuated BDNF-dependent p62 induction (Fig. 6b) . Like mTOR, p62 itself is also involved in the regulation of autophagy (Pankiv et al. 2007; Komatsu and Ichimura 2010) . The possibility of p62 reciprocally regulating mTOR activity therefore cannot be excluded. To address this issue, we knocked down p62 expression to test whether mTOR activity was affected. Results indicated that BDNF, as expected, enhanced phosphorylation of p70S6K; however, suppression of p62 by siRNA failed to exert any significant effects on p70S6K phosphorylation (Fig. 6c) . These results, together with the observations that p70S6K phosphorylation, occurring as early as 1 h after BDNF treatment, preceded p62 induction by BDNF after 4-h exposure, ruled out the possibility of p62 acting upstream of mTOR. Given that mTOR acts upstream of p62 in the cortical neurons exposed to BDNF, it is predicted that the observed neuroprotective effects of BDNF against 3-NP should be abolished by mTOR inhibition. Cell survival assays by Hoechst staining (Fig. 6d) and PI/Hoechst double staining (Fig. 6e ) both demonstrated that rapamycin was capable of completely abolishing BDNF-mediated neuroprotection against 3-NP toxicity. These results indicated that activation of mTOR is essential for BDNF-mediated induction of p62 and its neuroprotective effects against 3-NP.
Possible regulatory mechanisms responsible for p62 induction by BDNF While our results suggested a crucial role of mTOR in the BDNF-induced p62 expression, detailed molecular mechanisms underlying the observed p62 induction still remain unclear. In an attempt to address this issue, we characterized BDNF effects on p62 expression at mRNA levels.
Previously, it has been reported that human p62 pre-mRNA is alternatively spliced to generate three mature mRNA transcripts, the longest p62 mRNA variant 1 (p62-1) Fig. 5 Activation of mammalian target of rapamycin (mTOR) pathway by brain-derived neurotrophic factor (BDNF) in cortical neurons. (a and b) Cells were exposed to BDNF (100 ng/mL) at indicated times before detection of phosphor-mTOR at Ser2448 (mTOR-Pi) and mTOR in (a) and phosphor-p70 S6K at Thr389 (p70S6K-Pi) in (b) by western blotting. (c) Cortical cultures were exposed to BDNF (100 ng/mL) with or without rapamycin (1 nM) for 1 h before detection of p70S6K-Pi. N = 3 in (a-c). Mean AE SEM. * denotes p < 0.05 as compared to the corresponding control cultures without BDNF exposure in both (a) and (b). *, #, and § all denote p < 0.05 in (c).
encoding a 440-aa protein p62 isoform 1 and the other two shorter variants 2 and 3 (p62-2/3) encoding p62 isoform 2 (Wang et al. 2014) . We therefore designed PCR primers for these two p62 splicing variants to detect their expression levels. Results shown in Fig. 7(a) and (b) , respectively, indicated that BDNF failed to result in any significant effects Fig. 6 Involvements of mammalian target of rapamycin pathways in brain-derived neurotrophic factor (BDNF)-dependent p62 induction. (a) Cortical cultures were exposed to BDNF (100 ng/mL) with rapamycin (1 nM) or its solvent dimethyl sulfoxide (DMSO) for 6 h before detection of p62. N = 3. Mean AE SEM. * and # denote p < 0.05. (b) Cultures were pre-conditioned with BDNF (100 ng/mL) in the presence of rapamycin (1 nM) or its solvent DMSO for 8 h; this was followed by incubation in 3-NP (2.5 mM) or empty medium containing DMSO or rapamycin (1 nM) for additional 4 h before p62 detection. N = 3. Mean AE SEM. *, #, and § all denote p < 0.05. (c) Cortical cultures were transfected with p62 siRNA (1 lM) or negative control (NC) siRNA (1 lM) for 72 h; at the end of transfection, the cultures were exposed to BDNF (100 ng/mL) for 6 h before detection of phosphor-p70S6K at Thr389 (p70S6K-Pi). N = 4. Mean AE SEM. * denotes p < 0.05 as compared to the cultures transfected with NC siRNA without BDNF treatment. 'ns' denotes 'not significant'. (d and e) Cultures were exposed to BDNF (100 ng/mL) with the solvent DMSO or rapamycin (1 nM) for 8 h; this was followed by incubation in 3-NP (2.5 mM) or empty medium containing DMSO or rapamycin (1 nM) for additional 24 h before Hoechst staining (d) or 16 h for propidium iodide/Hoechst double staining (e) to, respectively, determine the extents of cell survival and death. N = 9 in (d) and N = 5 in (e). Mean AE SEM. *, #, and § all denote p < 0.05. on the expression levels of p62-1 and p62-2 based on RT-PCR. Furthermore, similar findings were observed when real-time quantitative PCR was conducted ( Fig. 7c and d) . These results indicated that BDNF does not affect the p62 expression at mRNA levels despite its effects on p62 expression at protein levels.
In our earlier publication, we have provided evidence that BDNF is capable of inducing the expression of transcription factor c-Jun that leads to expression of an antioxidant protein sulfiredoxin (Wu et al. 2012) . During the search of the promoter region of p62 gene, we also found c-Jun binding sites. Therefore, the potential roles of c-Jun in mediating the BDNF effects on p62 induction were tested. We found that knockdown of c-Jun partially inhibited BDNF-induced p62 expression (Fig. 8a) . In contrast, the p62 siRNA did not have any significant impacts on c-Jun expression (Fig. 8b) , thus excluding the potential regulatory effects of p62 on c-Jun expression. BDNF-induced c-Jun was partially, but statistically significantly, inhibited by rapamycin (Fig. 8c) , suggesting the possibility of mTOR acting upstream of c-Jun. However, c-jun siRNA failed to affect the phosphorylation states of p70S6K (Fig. 8d) , thus negating the possible regulatory roles of c-Jun on mTOR activation. Results shown in Fig. 8 appeared to suggest that BDNF-induced, and mTOR-dependent, induction of c-Jun contributes to p62 expression in primary rat cortical neurons.
Discussion
In this study, we provided experimental evidence showing that BDNF suppresses autophagy activation induced by mitochondrial toxin 3-NP with resultant neuroprotective effects via, at least in part, the induction of p62. BDNFdependent p62 expression requires mTOR activity and c-Jun induction. Together with the well-established roles of mTOR in suppressing autophagy, our findings appeared to suggest the signaling cascade of 'BDNF ? mTOR-Pi/p70S6K-Pi ? c-Jun ? p62 ? autophagy suppression ? 3-NP resistance' in cultured cortical neurons (Fig. 9) .
3-NP is known to induce autophagy both in vivo and in vitro. In the in vivo paradigms, biochemical analyses of the rat striatum treated with 3-NP via stereotaxic injection show activation of autophagy based on increased levels of beclin 1 and LC3-II (Zhang et al. 2009a ). In the in vitro paradigms, Fig. 7 Brain-derived neurotrophic factor (BDNF) does not affect the expression levels of p62 mRNA. Primary cortical cultures were treated with 100 ng/mL BDNF for indicated times before total RNA extraction for reverse transcription to generate cDNA and subsequent PCR (a and b) or real-time quantitative PCR (c and d). Glyceraldehyde 3-phosphate dehydrogenase was also amplified as an internal control. (a and c) and (b and d), respectively, demonstrate the quantitative results of mRNA species for p62-1 and p62-2. Note in all four panels, BDNF treatment failed to significantly alter the expression levels of either p62 mRNA species. In (a) and (b), representative agarose gel images and quantitative analysis from seven independent experiments using five different cultures are shown. In (c) and (d), quantitative results from seven independent experiments using five different cultures are shown. Mean AE SEM. 'ns' denotes 'not significant' as compared to control cultures without BDNF treatment.
3-NP has been shown to induce autophagy in SH-SY5Y cells (Solesio et al. 2013) . In our study, upon normalization to bactin individually, we found that it was mainly the LC3-II to be increased by 3-NP exposure, whereas LC3-I showed the tendency of increased expression but statistical significance was not reached (Figs. 1a and d) . However, such a differential regulation of LC3-I and LC3-II led to a less prominent increase in the ratio of LC3-II/LC3-I at 6 h subsequent to 3-NP exposure. During initiation of autophagosome formation, cytosolic LC3-I is cleaved to expose Gly-120 that is subsequently lipidated to produce LC3-II, which binds to a nascent double-membrane segment called a phagophore (Tanida et al. 2004) . Thus, the cytosolic ratio of LC3-II/ LC3-I may serve as an index of autophagy activity (Karim et al. 2007; Kadowaki and Karim 2009 ), especially when the total LC3 levels remain unchanged because, under such a condition, an increased level of LC3-II indicate a simultaneously decreased level of LC3-I, making the changes in the LC3-II/LC3-I ratio more prominent during autophagy induction. In the present study, 3-NP treatment increased LC3-I as well as LC3-II, hence the total LC3 levels, without significant changes in the LC3-II/LC3-I ratio at the 6-h time point (Fig. 1b) . Because LC3-II is crucial for the formation of autophagosomes, we predicted that an increased ratio of LC3-II/b-actin would also indicate a heightened extent of autophagosome formation, and hence autophagy, despite (1 lM) for 72 h; at the end of transfection, cortical cultures were exposed to BDNF (100 ng/mL) for 6 h before detection of p62 and c-Jun. N = 5. Mean AE SEM. * and # denote p < 0.05. (b) Cortical cultures were transfected with p62 siRNA (1 lM) or NC siRNA (1 lM) for 72 h; at the end of transfection, cortical cultures were exposed to BDNF (100 ng/ mL) for 6 h before detection of c-Jun. N = 4. Mean AE SEM. * and # denote p < 0.05 as compared to the respective controls cultures without BDNF exposure. 'ns' denotes 'not significant'. (c) Cortical cultures were exposed to 100 ng/mL BDNF with rapamycin (1 nM) or solvent dimethyl sulfoxide for 4 h before detection of c-Jun by western blotting. N = 9. Mean AE SEM. *, #, and § all denote p < 0.05. (d) Cortical cultures were transfected with c-jun siRNA (1 lM) or NC siRNA (1 lM) for 72 h; at the end of transfection, cortical cultures were exposed to BDNF (100 ng/mL) for 6 h before detection of phosphorp70S6K. N = 5. Mean AE SEM. * and # denote p < 0.05 as compared to the respective control cultures without BDNF exposure. 'ns' denotes 'not significant'.
insignificant changes in the LC3-II/LC3-I ratio. In addition to LC3-II/LC3-I ratio, we also examined subcellular localization of LC3 along with two organelle markers, COX-IV for mitochondria and LAMP-1 for lysosomes, as an alternative approach to confirm 3-NP-induced autophagy. In both sets of micrographs, we noted enhanced colocalization of COX-IV and LC3 as well as LAMP-1 and LC3, suggesting, respectively, mitophagy and formation of autolysosomes, in the cortical cultures exposed to 3-NP. Together, our results and data from earlier reports all suggest the capability of 3-NP in triggering autophagy.
Aside from autophagy activation by 3-NP, we also showed that 3-NP-induced cell death was significantly attenuated by Baf-A1 in cortical cultures, whereas Baf-A1 alone at 100 nM exerted modest neurotoxicity ( Fig. 2a and  b) ; further, the Baf-A1-mediated protective effect was confirmed with immunofluoroscence microscopy (Fig. 2c) and western blotting using the anti-MAP-2 antibody ( Fig. 2d and e) . The rationales behind these seemingly conflicting observations remain unknown and require further investigation. Nevertheless, Baf-A1-mediated neuroprotection against 3-NP is consistent with the previous report showing that 3-NP-induced striatal cell death is robustly attenuated by the autophagy inhibitors 3-methyladenine (3-MA) and Baf-A1 (Zhang et al. 2009a) . Baf-A1 has also been shown to inhibit the toxicity of cerebellar granule neurons induced by chloroquine, a widely prescribed antimalarial agent that is also used for the treatment of autoimmune diseases (Shacka et al. 2006) . In that study, the authors proposed that, at lower concentrations (< 1 nM), Baf-A1 inhibits chloroquine-induced apoptosis either upstream of or at the level of Bax that is independent of its inhibitory effects on the V-ATPase; in contrast, Baf-A1 at higher concentrations (10-100 nM) does not prevent chloroquine-dependent apoptosis and seems to inhibit autophagy with induction of Bax-dependent apoptosis (Shacka et al. 2006) . Therefore, in our study, Baf-A1 used at 100 nM likely induced neuronal apoptosis according to this previous report, which may explain why Baf-A1 alone at this dosage caused cytotoxicity independent of 3-NP exposure ( Fig. 2a and b) . Because Baf-A1 did not significantly alter the LC3-II/LC3-I ratio in the absence of 3-NP, it is also unlikely that Baf-A1 suppressed endogenous autophagy with resultant neuronal death. In the presence of 3-NP challenge, we found that Baf-A1 can suppress 3-NPmediated increases in LC3-II/LC3-I ratio (Fig. 2f and g ). These results appeared to be consistent with the contention that 3-NP triggers autophagy with resultant cytotoxicity, whereas Baf-A1 in part suppresses 3-NP-induced autophagy and therefore it is cytoprotective. Given its inhibitory effects on fusion of autophagosomes and lysosomes that may potentially lead to accumulation of autophagosomes containing LC3-II, we initially predicted that Baf-A1 should further enhance, rather than attenuate, the LC3-II/LC3-I ratio and were surprised at the results shown in Figs. 2(f) and (g). At present, we do not have a rational answer to this observation. Nevertheless, autophagy is not the only pathway for protein degradation in cells. Ubiquitin-proteasome system (UPS) is also critically involved, which may also interact with autophagy. For example, it has been shown that treatment with proteasome inhibitors confers resistance to oxidative injury by a pathway involving inhibition of the Akt-mTOR pathway and activation of autophagy in human retinal pigment epithelial cells (Tang et al. 2014) . Thus, it is not entirely impossible that inhibition of autophagic flux by Baf-A1 may have triggered other protein-degradation pathways, thereby leading to the observed decreases in LC3-II/LC3-I ratio (Fig. 2g) . Overall, the detailed mechanisms underlying the Baf-A1-mediated attenuation of 3-NP toxicity still remain unknown and require systematic investigation on the Baf-A1 effects at different concentrations. Since this study was focused on the neuroprotective effects of p62 induced by BDNF against mitochondrial dysfunction, the complicated roles of Baf-A1 in apoptosis/autophagy and its interaction with 3-NP were not further pursued.
The role of BDNF in autophagy regulation may vary in different model systems. Similar to our findings showing BDNF-dependent autophagy inhibition, a recent study demonstrated that BDNF-dependent hippocampal neuronal survival against medium withdrawal requires autophagy inhibition (Smith et al. 2014) . In contrast, however, it has also been reported that BDNF mediates autophagy activation under hypoxia in cortical neurons based on increased expression of LC3-II and formation of autophagosomes analyzed by immunofluorescence staining (Chen et al. 2013) . While the rationales behind this discrepancy between these results are still unknown, it should be kept in mind that experimental paradigms are different. In our studies, BDNF suppressed basal autophagy (Fig. 3a) as well as that inducible by 3-NP (Fig. 4d) , whereas under hypoxic conditions BDNF further enhanced hypoxia-induced autophagy that may have contributed to the maintenance of the balance Fig. 9 A scheme depicting the proposed signal transduction pathway in this study.
between degradation, synthesis, and the recycling of cellular components, together resulting in prevention of hypoxiainduced cell death (Chen et al. 2013) .
During the same time window in which BDNF suppressed autophagy, we observed time-dependent induction of p62 in cortical cultures (Fig. 3b) . Confocal microscopy also revealed p62 expression in the MAP-2-positive neuronal cells, mainly in the somata (Fig. 3c) . Interestingly, closer examination of Fig. 3(c) , especially those in the lower panels with higher magnification, further revealed weak staining signal in the nucleus. In the present study, we did not conduct subcellular fractionation to confirm whether p62 was expressed in the nucleus or not, but p62 protein has previously been shown to shuttle constantly between cytosol and nucleus. Indeed, two nuclear localization signals and one nuclear exporting signal has been identified (Pankiv et al. 2010) . In our work based on the immunocytochemistry, BDNF appeared to mainly increase p62 expression in the somata without significantly altering its nuclear contents.
Using siRNA to knock down its expression levels, we demonstrated that induction of p62 was causally linked to BDNF-mediated autophagy inhibition ( Fig. 4b and d) , suppression of 3-NP-induced caspase-3 cleavage (Fig. 4h) , and 3-NP resistance ( Fig. 4i and j) . In the SH-SY5Y cells treated with 5 mM 3-NP for 3 h, significantly decreased p62 expression accompanied by increased LC3-II/LC3-I ratio was reported (Solesio et al. 2013) . In our cortical cultures treated with 2.5 mM 3-NP for 4 h, we did not observe similar reduction in p62 expression (Fig. 4c) despite significant increase in LC3-II/LC3-I ratio (Fig. 4d) , total LC3 levels ( Fig. 4e) , and LC3-II/b-actin (Fig. 4f) . Closer examination of the immunoblots and quantitative data appeared to reveal a modest tendency towards decreasing p62 in the 3-NP-treated cultures (Fig. 4c) . One possible explanation is that the 3-NP concentration used in the present study (2.5 mM) was only half of that used in the previous report (Solesio et al. 2013 ). Different cell model systems, namely primary rat cortical neurons versus human neuroblastoma cell line SH-SY5Y, may be another confounding factor. Regardless of these discrepancies, both studies nevertheless demonstrated the critical roles of p62 in 3-NP-dependent autophagy regulation. Our study further emphasized that p62 is not just another marker protein for autophagy, manipulations of its expression, such as enhancement by BDNF or inhibition by siRNA, may have direct impacts on autophagy.
Another interesting finding in this work is that total LC3, in addition to LC3-II/LC3-I ratio, was increased by 3-NP in our experimental conditions (Fig. 1c and 4e) . The LC3B antibody used in the present study detected both cytoplasmic and nuclear expression, consistent with the previous report showing that LC3B was evenly distributed throughout the cytoplasm and detectable in the nucleus in cancer cell lines (Koukourakis et al. 2015) . While the underlying mechanisms remain to be further clarified, it has been reported that activating transcription factor-4 (ATF4) may directly bind to the cAMP-response element in the promoter of LC3B and regulate its expression in human leukemia-derived NB4 cells (Jiang et al. 2014) . Interestingly, treatment of the rat cochlear lateral wall fibrocytes with 3-NP resulted in an increased expression of ATF4 (Fujinami et al. 2010 ). Thus, it is possible that ATF4 may be involved in the observed increases of total LC3B in response to 3-NP challenges. However, this possibility requires experimental validation.
The correlation between mTOR activities and p62 is still controversial. It has been reported that p62 directly bound to mTOR as a component of mTOR complex 1 for its activation in prostate carcinoma CaP2 cells (Duran et al. 2011) . It has also been revealed that p62 siRNA inhibited phosphorylation of mTOR in lung adenocarcinoma cell lines PC9 and A549 cells (Nihira et al. 2014) . These results suggest that mTOR is a downstream target of p62. Conversely in our experimental model, BDNF-induced p62 expression was abolished by mTOR inhibitor rapamycin, both before ( Fig. 6a) and after ( Fig. 6b) exposure to 3-NP, indicating that mTOR is an upstream mediator of p62 in the cortical neurons treated with BDNF. The rationales behind this discrepancy between our findings and the previous reports (Duran et al. 2011; Nihira et al. 2014 ) are still unknown. One possibility is that cells subjected to different stimulators may respond differentially. Previous studies revealed that, in response to amino acids, p62 is essential for mTOR complex 1 activation (Duran et al. 2011) . Without exogenous stimuli or additional factors, knockdown of endogenous p62 caused mTOR inactivation (Nihira et al. 2014) . However, in our system, we observed mTOR-mediated p62 expression in response to treatments with the neurotrophic factor BDNF; furthermore, knockdown of p62 by siRNA failed to affect the phosphorylation of p70S6K, the downstream target of mTOR (Fig. 6c) , suggesting mTOR acts upstream of p62 but not vice versa. Another possibility is that different culture systems were used in these studies. The p62-mTOR pathway drives tumorigenesis in prostate carcinoma CaP2 cells (Duran et al. 2011) ; further, knockdown of endogenous p62 was also performed in lung adenocarcinoma tumor cell lines (Nihira et al. 2014) . However, in the present study, BDNF prevented cell death through mTOR-p62 pathway in the fully differentiated cortical neurons, rather than tumor cells. The possibility of differences in culture systems accounting for the observed discrepancy thus cannot be excluded. Together, these results reveal an intricate relationship between mTOR and p62 and their potential roles regulating cell survival in differentiated neurons and tumorigenesis in cancer cell lines.
The detailed mechanisms responsible for the observed p62 effects on LC3-ll/LC3-l ratio or autophagy activities remain to be further delineated. Conceivably, p62 is an adaptor protein in the formation of autophagosomes, yet we found that BDNF-induced p62 may, either directly or indirectly, decrease the extents of autophagy in the cortical neurons challenged with the mitochondrial inhibitor 3-NP. Recently, p62 has been proposed to function as a 'signaling hub' for diverse cellular events, including autophagy (Katsuragi et al. 2015) . In addition to its roles as an autophagy adaptor, for example, p62 interacts with the mTORC1 components Raptor and RagC on lysosomal membrane, leading to activation of mTORC1, which may then phosphorylate unc-51-like autophagy activating kinase-1/2 (ULK1/2) to suppress autophagy (Katsuragi et al. 2015) . In our study, we also demonstrated that BDNF may activate mTOR (Fig. 5) and, indeed, the induction of p62 by BDNF requires mTOR activity because rapamycin inhibited p62 expression (Fig. 6a  and b) . Similar results of rapamycin decreasing BDNFdependent p62 expression have also been recently reported by others (Smith et al. 2014) . These results together would predict that BDNF induces mTOR activation beginning at 1 h to suppress autophagy while inducing p62 beginning at 4 h; the increased p62 may then contribute to mTORC1 activation to further suppress autophagy, together creating a positive feed-forward loop reinforcing the inhibitory effects of BDNF on autophagy. While this appears to be an intriguing hypothesis, in such a scenario, one may predict that knockdown of p62 should in part disrupt this feedforward loop, resulting in a decreased mTOR activity. However, our additional experiments revealed that suppression of p62 expression did not have any significant impacts on mTOR activation, as indicated by the extents of p70S6K phosphorylation (Fig. 6c) . In addition, BDNF triggered mTOR at as early as 1 h based on the enhanced phosphorylation of p70S6K (Fig. 5b) , whereas BDNF-mediated suppression of autophagy did not occur until 4 h (Fig. 3a) , thus also excluding this possibility. Overall, the detailed mechanisms underlying the p62-dependent autophagy inhibition in our experimental paradigm require further investigation.
According to the results derived from both RT-PCR and real-time quantitative PCR, BDNF does not have significant effects on the steady-state levels of p62 transcripts (Fig. 7) , despite its ability in increasing the expression of p62 at protein levels (Fig. 3) . However, with identification of activating protein-1 (AP-1) binding sites in the p62 gene promoter as well as our earlier study showing the capability of BDNF in triggering c-Jun expression (Wu et al. 2012) , we demonstrated c-Jun as one of the transcription factors responsible for BDNF-dependent p62 expression downstream of mTOR based on siRNA-mediated knockdown experiments (Fig. 8) . Although the correlation between mTOR and AP-1 and/or c-Jun was less well studied, it has been reported that, in RAW264.7 macrophages, activation of mTOR leads to down-regulation of programmed cell death protein 4 that is a known repressor of AP-1, culminating in the activation of c-Jun (Kloos et al. 2015) . Whether such a molecular mechanism mediates BDNF/mTOR-dependent cJun induction in primary cortical neurons is an interesting question that still remains to be answered. Moreover, the detailed underlying mechanisms by which BDNF may affect the expression of p62 transcripts and proteins, such as transcriptional and translational efficiencies, mRNA and protein stabilities, as well as alternative splicing also requires further investigation.
In addition to attenuating 3-NP toxicity, p62 has been reported to confer cellular resistance against other types of stress. Similar to our results showing BDNF-mediated protective effects against 3-NP toxicity via p62 induction and autophagy inhibition, salidroside that is a glucoside of tyrosol found in the plant Rhodiola rosea has also been shown to protect cortical neurons against glutamate-induced apoptotic cell death via attenuation of the LC3-II/LC3-I ratio and increased expression of p62 (Yin et al. 2016) . Salidroside also inhibited the glutamate-induced dissociation of the Bcl-2/Beclin-1 complex; molecular analysis demonstrated that salidroside inhibited autophagy in response to glutamate by increasing the accumulation of cytoplasmic p53 in cortical neurons (Yin et al. 2016) . These data together demonstrated that the inhibition of autophagy could be responsible for the neuroprotective effects of salidroside on glutamate-induced neuronal apoptosis. Previously BDNF has been shown to prevent 3-NP-induced caspase-3-like activity and nuclear condensation; BDNF also decreased the levels of the proapoptotic protein Bim in mitochondrial and total cell lysates by increasing its degradation rates (Almeida et al. 2009 ). In an earlier report, we have demonstrated an important role of the anti-apoptotic Bcl-2 protein mediating BDNF-dependent protective effects against 3-NP ( Wu et al. 2009b) . Although in the present study, we did not examine the effects of p62 knockdown on Bcl-2 expression or its association with Beclin-1, p62 inhibition was found to partially, but statistically significantly, restore caspase-3 cleavage that was suppressed by BDNF pre-conditioning (Fig. 4h) , indicative of its anti-apoptotic potential as one of the neuroprotective mechanisms.
In conclusion, this study revealed a neuroprotective mechanism of BDNF in part via induction of mTOR activation and c-Jun expression, thereby leading to elevated p62 proteins with resultant attenuation of autophagy triggered by mitochondrial inhibition. These findings shed new lights on the beneficial actions of neurotrophic factors against mitochondrial inhibition involving autophagy regulation, thus carrying therapeutic implications in chronic neurodegenerative disorders in which mitochondrial dysfunction often plays a pivotal role. All experiments were conducted in compliance with the ARRIVE guidelines.
